Toxoplasma Encephalitis following Tandem Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature

por Kollu, Vidya, Magalhaes-Silverman, Margarida, Tricot, Guido, Ince, Dilek
Publicado 2018

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?

por Franqui-Machin, Reinaldo, Wendlandt, Erik B., Janz, Siegfried, Zhan, Fenghuang, Tricot, Guido
Publicado 2015

NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase

por Gu, Zhimin, Xia, Jiliang, Xu, Hongwei, Frech, Ivana, Tricot, Guido, Zhan, Fenghuang
Publicado 2017

A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma

por Radhakrishnan, Sabarinath V., Boyer, Michael, Sherwin, Catherine M., Zangari, Maurizio, Tricot, Guido
Publicado 2019

Composite Patient Reports: A Laboratory Informatics Perspective and Pilot Project for Personalized Medicine and Translational Research

por Gundlapalli, Adi V., Delgado, Julio C., Jackson, Brian R., Tricot, Guido J., Hill, Harry R.
Publicado 2009

C-Reactive Protein Monitoring Predicts Neutropenic Fever Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

por Kollu, Vidya, Mott, Sarah L, Khan, Rafiullah, Farooq, Umar, Jethava, Yogesh, Dilek, Ince, Tricot, Guido
Publicado 2018

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma

por Ramani, Vishnu C., Zhan, Fenghuang, He, Jianbo, Barbieri, Paola, Noseda, Alessandro, Tricot, Guido, Sanderson, Ralph D.
Publicado 2015

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma

por Gu, Chunyan, Jing, Xuefang, Holman, Carol, Sompallae, Ramakrishna, Zhan, Fenghuang, Tricot, Guido, Yang, Ye, Janz, Siegfried
Publicado 2018

Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma

por Gu, Chunyan, Jing, Xuefang, Holman, Carol, Sompallae, Ramakrishna, Zhan, Fenghuang, Tricot, Guido, Yang, Ye, Janz, Siegfried
Publicado 2019

Nek2 Is a Novel Regulator of B Cell Development and Immunological Response

por Gu, Zhimin, Zhou, Wen, Huang, Junwei, Yang, Ye, Wendlandt, Erik, Xu, Hongwei, He, Xiao, Tricot, Guido, Zhan, Fenghuang
Publicado 2014

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma

por Yang, Ye, Zhou, Wen, Xia, Jiliang, Gu, Zhimin, Wendlandt, Erik, Zhan, Xin, Janz, Siegfried, Tricot, Guido, Zhan, Fenghuang
Publicado 2014

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus

por Kelly, Kevin R., Espitia, Claudia M., Zhao, Weiguo, Wendlandt, Erik, Tricot, Guido, Zhan, Fenghuang, Carew, Jennifer S., Nawrocki, Steffan T.
Publicado 2015

Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid

por Xia, Jiliang, Xu, Hongwei, Zhang, Xiaoyan, Allamargot, Chantal, Coleman, Kristen L., Nessler, Randy, Frech, Ivana, Tricot, Guido, Zhan, Fenghuang
Publicado 2017

Inhibition of Nek2 by Small Molecules Affects Proteasome Activity

por Meng, Lingyao, Carpenter, Kent, Mollard, Alexis, Vankayalapati, Hariprasad, Warner, Steven L., Sharma, Sunil, Tricot, Guido, Zhan, Fenghuang, Bearss, David J.
Publicado 2014

Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and Progression

por Li, Can, Wendlandt, Erik B., Darbro, Benjamin, Xu, Hongwei, Thomas, Gregory S., Tricot, Guido, Chen, Fangping, Shaughnessy, John D., Zhan, Fenghuang
Publicado 2021

Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma

por Alqazaqi, Raghad, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John, Zhan, Fenghuang, Tricot, Guido, van Rhee, Frits, Al Hadidi, Samer
Publicado 2022

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma

por Nadiminti, Kalyan, Singh Abbi, Kamal Kant, Mott, Sarah L, Dozeman, Lindsay, Tricot, Annick, Schultz, Allyson, Behrends, Sonya, Zhan, Fenghuang, Tricot, Guido
Publicado 2017

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS

por Guo, Wancheng, Zhan, Anne, Mery, David E., Munshi, Manit N., Makhoul, Oussama, Baily, Clyde, Zangari, Maurizio, Tricot, Guido, Peng, Hongling, Shaughnessy, John D.
Publicado 2023

Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome

por Gu, Chunyan, Holman, Carol, Sompallae, Ramakrishna, Jing, Xuefang, Tomasson, Michael, Hose, Dirk, Seckinger, Anja, Zhan, Fenghuang, Tricot, Guido, Goldschmidt, Hartmut, Yang, Ye, Janz, Siegfried
Publicado 2018

Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma

por Zhan, Xin, Yu, Wenjie, Franqui-Machin, Reinaldo, Bates, Melissa L., Nadiminti, Kalyan, Cao, Huojun, Amendt, Brad A., Jethava, Yogesh, Frech, Ivana, Zhan, Fenghuang, Tricot, Guido
Publicado 2017